Company research
AERIE PHARMACEUTICALS INC
CIK 1337553Updated Nov 16, 2026
Securities
Historical securities (1)
AERI · NASDAQ · equity · closed Nov 21, 2022AERI price & chart
Historical security
This listing closed Nov 21, 2022. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2021 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 431,391,000Source | 402,045,000Source | 452,608,000Source | 285,044,000Source |
| Property, Plant and Equipment, NetUSD | 51,472,000Source | 54,260,000Source | 58,147,000Source | 60,525,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 37,187,000Source | 151,570,000Source | 143,940,000Source | 202,818,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 68,828,000Source | 56,022,000Source | 38,354,000Source | 2,715,000Source |
| Inventory, NetUSD | 40,410,000Source | 27,059,000Source | 21,054,000Source | 10,112,000Source |
| Assets, CurrentUSD | 355,650,000Source | 331,755,000Source | 376,342,000Source | 220,175,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 16,611,000Source | 8,310,000Source | 7,744,000Source | 4,530,000Source |
| Operating Lease, Right-of-Use AssetUSD | 22,669,000Source | 14,084,000Source | 16,523,000Source | — |
| Other Assets, NoncurrentUSD | 1,600,000Source | 1,946,000Source | 1,596,000Source | 4,344,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 448,724,000Source | 378,077,000Source | 285,658,000Source | 57,238,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 48,000Source | 47,000Source | 46,000Source | 45,000Source |
| Additional Paid in CapitalUSD | 1,136,656,000Source | 1,103,074,000Source | 1,062,996,000Source | 924,180,000Source |
| Retained Earnings (Accumulated Deficit)USD | -1,153,911,000Source | -1,079,101,000Source | -896,000,000Source | -696,419,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -126,000Source | -52,000Source | -92,000Source | 0Source |
| Stockholders' Equity Attributable to ParentUSD | -17,333,000Source | 23,968,000Source | 166,950,000Source | 227,806,000Source |
| Liabilities and EquityUSD | 431,391,000Source | 402,045,000Source | 452,608,000Source | 285,044,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 124,991,000Source | 104,472,000Source | 83,648,000Source | 50,784,000Source |
| Operating Lease, Liability, CurrentUSD | 4,365,000Source | 4,923,000Source | 5,502,000Source | — |
| Accounts Payable, CurrentUSD | 8,285,000Source | 8,826,000Source | 12,770,000Source | 12,403,000Source |
| Operating Lease, Liability, NoncurrentUSD | 21,751,000Source | 10,206,000Source | 12,102,000Source | — |
| Other Liabilities, NoncurrentUSD | 3,140,000Source | 2,168,000Source | 1,257,000Source | 6,454,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 112,341,000Source | 90,723,000Source | 65,376,000Source | 38,381,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 139,801,000Source | 240,364,000Source | 309,190,000Source | — |
| Short-term InvestmentsUSD | 102,614,000Source | 88,794,000Source | 165,250,000Source | 0Source |
cash flow · annual statements
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 29,524,000Source | 40,095,000Source | 45,093,000Source | 38,728,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 12,806,000Source | 17,668,000Source | 35,639,000Source | 2,715,000Source |
| Increase (Decrease) in InventoriesUSD | 12,101,000Source | 5,166,000Source | 10,257,000Source | 9,689,000Source |
| Deferred Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -99,154,000Source | -64,690,000Source | -150,430,000Source | -152,576,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -18,201,000Source | 73,179,000Source | -183,247,000Source | 20,789,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 3,291,000Source | 3,100,000Source | 9,958,000Source | 31,313,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 2,972,000Source | -859,000Source | 274,799,000Source | 137,036,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | 0Source | 0Source | -336,000Source | -683,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -114,383,000Source | 7,630,000Source | -58,878,000Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 37,187,000Source | 151,570,000Source | 143,940,000Source | — |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 4,744,000Source | 5,034,000Source | 6,496,000Source | 1,774,000Source |
| Additional Financial Items | ||||
| AmortizationUSD | 31,101,000Source | 27,792,000Source | 12,976,000Source | — |
| Share-based Payment Arrangement, ExpenseUSD | 29,524,000Source | 40,095,000Source | 45,093,000Source | 38,728,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | 1,577,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 139,801,000Source | 240,364,000Source | 309,190,000Source | — |
| DepreciationUSD | 6,399,000Source | 6,366,000Source | 5,138,000Source | 2,442,000Source |
| Equity Securities, FV-NI, Unrealized Gain (Loss)USD | — | 1,300,000Source | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | 270,000Source |
| Foreign Currency Transaction Gain (Loss), UnrealizedUSD | — | — | — | 200,000Source |
| Income Tax Expense (Benefit)USD | 593,000Source | 5,245,000Source | -90,000Source | 3,000Source |
| Net Income (Loss) Attributable to ParentUSD | -74,810,000Source | -183,101,000Source | -199,581,000Source | -232,569,000Source |
| Operating Lease, ExpenseUSD | 5,900,000Source | 5,600,000Source | 5,300,000Source | — |
| Other Nonoperating Income (Expense)USD | -27,863,000Source | -22,166,000Source | -12,179,000Source | -22,824,000Source |
| Proceeds from Issuance of Common StockUSD | — | 0Source | 0Source | 135,972,000Source |
income statement · annual statements
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|
| Total RevenueUSD | 194,134,000Source | 83,138,000Source | 69,888,000Source | 24,181,000Source |
| Cost of RevenueUSD | 26,846,000Source | 25,333,000Source | — | 641,000Source |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 137,805,000Source | 137,184,000Source | 138,402,000Source | 120,614,000Source |
| Operating Income (Loss)USD | -46,354,000Source | -155,690,000Source | -187,492,000Source | -209,742,000Source |
| Other Nonoperating Income (Expense)USD | -27,863,000Source | -22,166,000Source | -12,179,000Source | -22,824,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -74,217,000Source | -177,856,000Source | -199,671,000Source | -232,566,000Source |
| Income Tax Expense (Benefit)USD | 593,000Source | 5,245,000Source | -90,000Source | 3,000Source |
| Net Income (Loss) Attributable to ParentUSD | -74,810,000Source | -183,101,000Source | -199,581,000Source | -232,569,000Source |
| Earnings Per Share, BasicUSD per share | -1.61Source | — | — | — |
| Earnings Per Share, DilutedUSD per share | -1.61Source | — | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 46,336,346Source | — | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 46,336,346Source | — | — | — |
| Additional Financial Items | ||||
| Costs and ExpensesUSD | 240,488,000Source | 238,828,000Source | 257,380,000Source | 233,923,000Source |
| Current Income Tax Expense (Benefit)USD | 593,000Source | 5,245,000Source | -90,000Source | 3,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | 270,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -138,323,000Source | -143,349,000Source | -153,620,000Source | — |
| Interest Expense, DebtUSD | 28,900,000Source | 26,500,000Source | 15,300,000Source | — |
| Interest Income (Expense), NetUSD | 100,000Source | 2,000,000Source | 3,000,000Source | 3,400,000Source |
| Operating Lease, ExpenseUSD | 5,900,000Source | 5,600,000Source | 5,300,000Source | — |
| Other Cost of Operating RevenueUSD | — | — | 4,833,000Source | — |
| Research and Development ExpenseUSD | 75,837,000Source | 74,007,000Source | 91,378,000Source | 86,123,000Source |